MiR-200c targets CDK2 and suppresses tumorigenesis in renal cell carcinoma

Xuegang Wang, Xuanyu Chen, Weiwei Han, Anming Ruan, Li Chen, Rong Wang, Zhenghong Xu, Pei Xiao, Xing Lu, Yan Zhao, Jia Zhou, Shaoyong Chen, Quansheng Du, Hongmei Yang, Xiaoping Zhang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

miRNA expression profiles are widely investigated in the major cancers, but their specific roles and functions in cancers have not yet to be fully elucidated. In this study, miRNA expression profiles were determined in clear cell renal cell carcinomas (ccRCC) and in matched normal kidney tissues by using a miRNA microarray platform which covers a total of 851 human miRNAs. Differential expression of 74 miRNAs were identified between ccRCC specimens and their matched adjacent noncancerous tissues, of which 30 were significantly upregulated in ccRCCs, and the other 44 were downregulated (fold change 2, P < 0.05). Interestingly, miR-200c was commonly downregulated in ccRCC specimens and ccRCC cell lines with significant functional consequences. Growth curve and FACS assay indicated that overexpression of miR-200c suppressed cell growth and induced cell-cycle arrest at G0-G1 phases in SN12-PM6 and 786-O cells. Furthermore, miR-200c could suppress in vivo tumor growth of SN12-PM6 cells in mice. Bioinformatics exposed cyclin-dependent kinase 2 (CDK2) as a potential target of miR-200c, which was validated using a luciferase reporter assay. Mechanistic investigations revealed that miR-200c was directly responsible for suppressing the expression of CDK2 in ccRCC cell lines and xenografts. Taken together, miR-200c plays an antioncogenic role in ccRCC, through controlling cell growth and cell-cycle progression by downregulating the G1-S regulator CDK2. Implications: miR-200c exerts its novel antioncogenic function in renal cell carcinoma by controlling CDK2-dependent cell growth and cell-cycle progression.

Original languageEnglish (US)
Pages (from-to)1567-1577
Number of pages11
JournalMolecular Cancer Research
Volume13
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Cyclin-Dependent Kinase 2
Renal Cell Carcinoma
Carcinogenesis
MicroRNAs
Growth
Down-Regulation
Cell Cycle
Cell Line
Neoplasms
Cell Cycle Resting Phase
G1 Phase
Cell Cycle Checkpoints
Computational Biology
Luciferases
Heterografts
Kidney

ASJC Scopus subject areas

  • Molecular Biology
  • Oncology
  • Cancer Research

Cite this

Wang, X., Chen, X., Han, W., Ruan, A., Chen, L., Wang, R., ... Zhang, X. (2015). MiR-200c targets CDK2 and suppresses tumorigenesis in renal cell carcinoma. Molecular Cancer Research, 13(12), 1567-1577. https://doi.org/10.1158/1541-7786.MCR-15-0128

MiR-200c targets CDK2 and suppresses tumorigenesis in renal cell carcinoma. / Wang, Xuegang; Chen, Xuanyu; Han, Weiwei; Ruan, Anming; Chen, Li; Wang, Rong; Xu, Zhenghong; Xiao, Pei; Lu, Xing; Zhao, Yan; Zhou, Jia; Chen, Shaoyong; Du, Quansheng; Yang, Hongmei; Zhang, Xiaoping.

In: Molecular Cancer Research, Vol. 13, No. 12, 01.12.2015, p. 1567-1577.

Research output: Contribution to journalArticle

Wang, X, Chen, X, Han, W, Ruan, A, Chen, L, Wang, R, Xu, Z, Xiao, P, Lu, X, Zhao, Y, Zhou, J, Chen, S, Du, Q, Yang, H & Zhang, X 2015, 'MiR-200c targets CDK2 and suppresses tumorigenesis in renal cell carcinoma', Molecular Cancer Research, vol. 13, no. 12, pp. 1567-1577. https://doi.org/10.1158/1541-7786.MCR-15-0128
Wang, Xuegang ; Chen, Xuanyu ; Han, Weiwei ; Ruan, Anming ; Chen, Li ; Wang, Rong ; Xu, Zhenghong ; Xiao, Pei ; Lu, Xing ; Zhao, Yan ; Zhou, Jia ; Chen, Shaoyong ; Du, Quansheng ; Yang, Hongmei ; Zhang, Xiaoping. / MiR-200c targets CDK2 and suppresses tumorigenesis in renal cell carcinoma. In: Molecular Cancer Research. 2015 ; Vol. 13, No. 12. pp. 1567-1577.
@article{6a9ca8757e5a479cb4e0caa725e6b527,
title = "MiR-200c targets CDK2 and suppresses tumorigenesis in renal cell carcinoma",
abstract = "miRNA expression profiles are widely investigated in the major cancers, but their specific roles and functions in cancers have not yet to be fully elucidated. In this study, miRNA expression profiles were determined in clear cell renal cell carcinomas (ccRCC) and in matched normal kidney tissues by using a miRNA microarray platform which covers a total of 851 human miRNAs. Differential expression of 74 miRNAs were identified between ccRCC specimens and their matched adjacent noncancerous tissues, of which 30 were significantly upregulated in ccRCCs, and the other 44 were downregulated (fold change 2, P < 0.05). Interestingly, miR-200c was commonly downregulated in ccRCC specimens and ccRCC cell lines with significant functional consequences. Growth curve and FACS assay indicated that overexpression of miR-200c suppressed cell growth and induced cell-cycle arrest at G0-G1 phases in SN12-PM6 and 786-O cells. Furthermore, miR-200c could suppress in vivo tumor growth of SN12-PM6 cells in mice. Bioinformatics exposed cyclin-dependent kinase 2 (CDK2) as a potential target of miR-200c, which was validated using a luciferase reporter assay. Mechanistic investigations revealed that miR-200c was directly responsible for suppressing the expression of CDK2 in ccRCC cell lines and xenografts. Taken together, miR-200c plays an antioncogenic role in ccRCC, through controlling cell growth and cell-cycle progression by downregulating the G1-S regulator CDK2. Implications: miR-200c exerts its novel antioncogenic function in renal cell carcinoma by controlling CDK2-dependent cell growth and cell-cycle progression.",
author = "Xuegang Wang and Xuanyu Chen and Weiwei Han and Anming Ruan and Li Chen and Rong Wang and Zhenghong Xu and Pei Xiao and Xing Lu and Yan Zhao and Jia Zhou and Shaoyong Chen and Quansheng Du and Hongmei Yang and Xiaoping Zhang",
year = "2015",
month = "12",
day = "1",
doi = "10.1158/1541-7786.MCR-15-0128",
language = "English (US)",
volume = "13",
pages = "1567--1577",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - MiR-200c targets CDK2 and suppresses tumorigenesis in renal cell carcinoma

AU - Wang, Xuegang

AU - Chen, Xuanyu

AU - Han, Weiwei

AU - Ruan, Anming

AU - Chen, Li

AU - Wang, Rong

AU - Xu, Zhenghong

AU - Xiao, Pei

AU - Lu, Xing

AU - Zhao, Yan

AU - Zhou, Jia

AU - Chen, Shaoyong

AU - Du, Quansheng

AU - Yang, Hongmei

AU - Zhang, Xiaoping

PY - 2015/12/1

Y1 - 2015/12/1

N2 - miRNA expression profiles are widely investigated in the major cancers, but their specific roles and functions in cancers have not yet to be fully elucidated. In this study, miRNA expression profiles were determined in clear cell renal cell carcinomas (ccRCC) and in matched normal kidney tissues by using a miRNA microarray platform which covers a total of 851 human miRNAs. Differential expression of 74 miRNAs were identified between ccRCC specimens and their matched adjacent noncancerous tissues, of which 30 were significantly upregulated in ccRCCs, and the other 44 were downregulated (fold change 2, P < 0.05). Interestingly, miR-200c was commonly downregulated in ccRCC specimens and ccRCC cell lines with significant functional consequences. Growth curve and FACS assay indicated that overexpression of miR-200c suppressed cell growth and induced cell-cycle arrest at G0-G1 phases in SN12-PM6 and 786-O cells. Furthermore, miR-200c could suppress in vivo tumor growth of SN12-PM6 cells in mice. Bioinformatics exposed cyclin-dependent kinase 2 (CDK2) as a potential target of miR-200c, which was validated using a luciferase reporter assay. Mechanistic investigations revealed that miR-200c was directly responsible for suppressing the expression of CDK2 in ccRCC cell lines and xenografts. Taken together, miR-200c plays an antioncogenic role in ccRCC, through controlling cell growth and cell-cycle progression by downregulating the G1-S regulator CDK2. Implications: miR-200c exerts its novel antioncogenic function in renal cell carcinoma by controlling CDK2-dependent cell growth and cell-cycle progression.

AB - miRNA expression profiles are widely investigated in the major cancers, but their specific roles and functions in cancers have not yet to be fully elucidated. In this study, miRNA expression profiles were determined in clear cell renal cell carcinomas (ccRCC) and in matched normal kidney tissues by using a miRNA microarray platform which covers a total of 851 human miRNAs. Differential expression of 74 miRNAs were identified between ccRCC specimens and their matched adjacent noncancerous tissues, of which 30 were significantly upregulated in ccRCCs, and the other 44 were downregulated (fold change 2, P < 0.05). Interestingly, miR-200c was commonly downregulated in ccRCC specimens and ccRCC cell lines with significant functional consequences. Growth curve and FACS assay indicated that overexpression of miR-200c suppressed cell growth and induced cell-cycle arrest at G0-G1 phases in SN12-PM6 and 786-O cells. Furthermore, miR-200c could suppress in vivo tumor growth of SN12-PM6 cells in mice. Bioinformatics exposed cyclin-dependent kinase 2 (CDK2) as a potential target of miR-200c, which was validated using a luciferase reporter assay. Mechanistic investigations revealed that miR-200c was directly responsible for suppressing the expression of CDK2 in ccRCC cell lines and xenografts. Taken together, miR-200c plays an antioncogenic role in ccRCC, through controlling cell growth and cell-cycle progression by downregulating the G1-S regulator CDK2. Implications: miR-200c exerts its novel antioncogenic function in renal cell carcinoma by controlling CDK2-dependent cell growth and cell-cycle progression.

UR - http://www.scopus.com/inward/record.url?scp=84950321986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950321986&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-15-0128

DO - 10.1158/1541-7786.MCR-15-0128

M3 - Article

VL - 13

SP - 1567

EP - 1577

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 12

ER -